Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy
Jan 7, 2022
Jan 4, 2022
Major financial hardship common after cancer diagnosis, despite insurance
Dec 24, 2021
Thank you for another extraordinary year, replete with extraordinary work!
Dec 21, 2021
The Winter 2021 newsletter for Lung-MAP participating sites is now available.
Dec 17, 2021
Dec 13, 2021
Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo
Dec 11, 2021
Analyses presented at ASH 2021 find statistical models can predict risk of early death with non-intensive AML therapy